Srinivas Akkaraju Syros Pharmaceuticals, Inc. (SYRS) insider trading activity

Srinivas Akkaraju is of Syros Pharmaceuticals, Inc.. Currently has a direct ownership of 9,333 shares of SYRS, which is worth approximately $18,759. The most recent transaction as insider was on Sep 16, 2024, when has been sold 2,667 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.33K

40.01% 3M change

250.08% 12M change

Total Value Held $18,759

SRINIVAS AKKARAJU Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 16 2024	BUY Exercise of conversion of derivative security	-	2,667 Added 22.23%	9,333 Common Stock
Jun 01 2024	BUY Exercise of conversion of derivative security	-	4,000 Added 37.5%	6,666 Common Stock
Sep 16 2023	BUY Exercise of conversion of derivative security	-	2,666 Added 50.0%	2,666 Common Stock

Also insider at

KDNY

CHINOOK THERAPEUTICS, INC. Healthcare

Director

ICPT

INTERCEPT PHARMACEUTICALS, INC. Healthcare

Director

SRRK

Scholar Rock Holding Corp Healthcare

JYAC

Jiya Acquisition Corp. Financial Services

Director

VTVT

vTv Therapeutics Inc. Healthcare

MLYS

Mineralys Therapeutics, Inc.

Director

ALMS

ALUMIS INC.